Presentation

Uses

For the prevention and treatment of iron deficiency anaemia in piglets.

Dosage and administration

Use only automatic syringe equipment
Swab the septum before use. The product is administered as a single 1 mL (200 mg iron) dose by deep intramuscular injection into the hind limb midway between the stifle joint and the base of the tail. Injections should be administered as follows:
For the prevention of iron deficiency anaemia: not later than the third day of life.
For the treatment of iron deficiency anaemia: at the onset of clinical anaemia, normally within the first three weeks of life.

Contra-indications, warnings, etc

Withdrawal period: zero days

Pharmaceutical precautions

Do not store above 25°. Protect from light. Each bottle is sealed in a transparent sachet; the sachet should not be opened until the bottle is required for use. Avoid the introduction of contamination during use.
Following withdrawal of the first dose, use the product within 28 days.
Keep out of reach of children.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Legal category

POM-VPS

Packaging Quantities

Carton containing 100 mL collapsible plastic bottle.

Further information

Precautions to be taken by the person administering the product to animals: in case of accidental self-injection or ingestion seek medical advice taking bottle and package leaflet to the physician. Wash hands after use.
There are normally no undesirable side effects associated with the use of the product. Its use does not result in permanent staining of the injected muscle tissue.
Overdosage with the product is unlikely to result in signs of intoxication.

Contra-indications

Special warnings for each target species

Special precautions for use

Adverse reactions

There are normally no undesirable side effects associated with the use of the product. Its use does not result in permanent staining of the injected muscle tissue.

Use during pregnancy or lactation

Not applicable

Interactions

There are no known interactions between the product and other medicaments. There are no known other forms of interaction. Do not mix with other products prior to administration.

Amounts to be administered and administration route

Use only automatic syringe equipment. Swab the septum before use. The product is administered as a single 1 mL (200 mg iron) dose by deep intramuscular injection into the hind limb midway between the stifle joint and the base of the tail. Injections should be administered as follows:

For the prevention of Iron deficiency anaemia: not later than the third day of life.

For the treatment of Iron deficiency anaemia: at the onset of clinical anaemia, normally within the first three weeks of life.

Overdose

Overdosage with the product is unlikely to result in signs of intoxication.

Withdrawal periods

Zero Days

Pharmacological particulars

Pharmacodynamic properties

Injectable iron-carbohydrate complexes are established haematinic agents in veterinary medicine. Following intramuscular injection, the complex is absorbed and metabolised to release the iron for utilisation and/or storage in accordance with the nutritional status of the animal. In iron deficient states, the iron is utilised for the synthesis of haemoglobin and other iron-containing molecules. Excess iron is stored principally in the liver.

Pharmacokinetic properties

Absorption of the product has been shown to be rapid. Over 95% of the administered iron (1mL/200 mg iron administered at three days of age) was absorbed by 24 hours after injection. Use of the product does not result in permanent staining of the injected muscle tissue.

Pharmaceutical particulars

The sachet should not be opened until the product is required for use. Avoid the introduction of contamination during use.

Special precautions for storage

Immediate packaging

Disposal

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing Authorisation Holder (if different from distributor)

-

Marketing authorisation number

Vm 14094/4000.

Date of the first authorisation or date of renewal

30 August 1995

Date of revision of the text

February 2010

Any other information

Special precautions for the person administering the veterinary medicinal product to animals: Care should be taken to avoid accidental self injection.In the event of accidental self injection seek medical advice. Wash hands after use.